Xconomy Boston

See Which Life Sciences Companies Are Getting The $25M State Tax Breaks

Luke Timmerman12/24/09Leave a Comment

(Page 2 of 2)

9T. OmniGuide, Cambridge—$540,000

11. Constellation Pharmaceuticals, Cambridge—$513,252

12. FoldRx Pharmaceuticals, Cambridge—$510,000

13. PharmaSphere, Worcester—$360,000

14. Alnylam Pharmaceuticals, Cambridge—$300,000

14T. Facet Solutions, Hopkinton—$300,000

14T. GTC Biotherapeutics, Framingham—$300,000

14T. Interlace Medical, Framingham—$300,000

14T. NeuroMetrix, Waltham—$300,000

14T. Nova Biomedical, Waltham—$300,000

14T. Still River Systems, Littleton—$300,000

14T. Tolerx, Cambridge—$300,000

22. Zoll Medical, Chelmsford—$267,500

23. Organogenesis, Canton—$245,240

24. Hologic, Bedford—$220,000

25. Lightlab Imaging, Westford—$188,951

26. STD Med, Stoughton—$121,000

27. Dyax, Cambridge—$100,000

28. TEI Biosciences, South Boston—$27,000


Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.

Single PageCurrently on Page: 1 2 previous page

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.